Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by theNormon Oct 02, 2022 5:52am
278 Views
Post# 34999970

YouTube

YouTube
In the last video, an admittedly loosely scripted affair, George stated they've gone from @20 inquires to literally 100's. Purchase orders require a process of dd, quotes and consultations b4 po is issued. I think it was more a case of playing possum ending the qtr w/o a strong general news release. Many people like me are heavily invested and hesitant to get further overweight. Bid support dropped as low as .22 last week. Paradigm sales were options or special wts BECAUSE they achieved large vol sale w/o tanking the sp. There was obviously a gentleman's agreement to buy all they were selling. This is very bullish signal to me. IMO all I need to do is be patient until sales, UK standard of care, US standard of care and GEHC spinout unlock the hidden value here. A good investor confirms info through quality links. They don't blame people for their choices to buy or sell. SEDAR is a pain to learn but with experience you learn to speed read and scan to the important topics/sections. VPT has minimal options left below .40 and the only significant amount of warrants are .70 with an acceleration clause. This is a rare retail dream with very little risk, that's why I call it my second unicorn stock. God willing we shall be back above .50 on our way to multi-dollar land very soon. Tea leaves tell me by 3rd wk Oct. Cheers
<< Previous
Bullboard Posts
Next >>